Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study.
Hietikko R, Kilpeläinen TP, Kenttämies A, Ronkainen J, Ijäs K, Lind K, Marjasuo S, Oksala J, Oksanen O, Saarinen T, Savolainen R, Taari K, Tammela TLJ, Mirtti T, Natunen K, Auvinen A, Rannikko A.
Hietikko R, et al. Among authors: savolainen r.
Cancer Imaging. 2020 Oct 9;20(1):72. doi: 10.1186/s40644-020-00351-w.
Cancer Imaging. 2020.
PMID: 33036660
Free PMC article.